Chongqing Genrix Biopharmaceutical Co., Ltd. (SHA:688443)
China · Delayed Price · Currency is CNY 25.30
+1.16 (4.81%)
At close: Sep 30, 2026
Chongqing Genrix Biopharmaceutical Employees
Chongqing Genrix Biopharmaceutical had 1,133 employees as of June 30, 2026. The number of employees increased by 149 or 15.14% since the number was reported on December 31, 2025.
Employees
1,133
Change
149
Growth
15.14%
Revenue / Employee
298.71K CNY
Profits / Employee
-496.49K CNY
Market Cap
9.28B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 1,133 | 149 | 15.14% |
| Dec 31, 2025 | 984 | 241 | 32.44% |
| Dec 31, 2024 | 743 | 196 | 35.83% |
| Dec 31, 2023 | 547 | 155 | 39.54% |
| Dec 31, 2022 | 392 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Chengzhi | 4,462 |
| Pacific Shuanglin Bio-pharmacy | 2,755 |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 2,360 |
| Aurisco Pharmaceutical | 2,026 |
| Vcanbio Cell & Gene Engineering Corp., | 1,935 |
| Jiangxi Fushine Pharmaceutical | 1,663 |
| Liaoning Chengda Biotechnology | 1,585 |
| Bio-Thera Solutions | 1,471 |